Fy. Lee et al., PLASMA INTERLEUKIN-6 LEVELS IN PATIENTS WITH CIRRHOSIS - RELATIONSHIPTO ENDOTOXEMIA, TUMOR-NECROSIS-FACTOR-ALPHA, AND HYPERDYNAMIC CIRCULATION, Scandinavian journal of gastroenterology, 31(5), 1996, pp. 500-505
Liver cirrhosis with portal hypertension is associated with hyperdynam
ic circulation characterized by generalized vasodilatation and increas
ed cardiac output and regional blood flows. Patients with liver cirrho
sis present with increased levels of interleukin-6 (IL-6), which may i
nhibit vascular smooth-muscle contraction. We investigated whether inc
reased plasma IL-6 levels contribute to the pathogenesis of hyperdynam
ic circulation observed in cirrhotic patients and whether they are cor
related with plasma tumor necrosis factor-alpha (TNF-alpha) and endoto
xin concentrations. Methods: In 58 consecutive cirrhotic patients and
34 healthy subjects the plasma concentrations of TNF-alpha and IL-6 we
re measured with enzyme-linked immunosorbent assay, and endotoxin dete
rminations with a limulus assay. In addition, 52 cirrhotic patients un
derwent a hemodynamic study using Swan-Ganz catheterization. Results:
Plasma TNF-alpha, IL-6, and endotoxin levels were significantly higher
in cirrhotic patients than in healthy subjects (7.3 +/- 0.2 versus 5.
8 +/- 0.1 pg/ml, 6.4 +/- 0.8 versus 2.0 +/- 0.2 pg/ml, and 7.6 +/- 1.2
versus 2.8 +/- 0.3 pg/ml, respectively; p < 0.01). In cirrhotic patie
nts the plasma levels of TNF-alpha, IL-6, and endotoxin progressively
increased in relation to the severity of liver dysfunction (graded by
Pugh's classification). A significant correlation was observed between
plasma TNF-alpha and IL-6 levels (r = 0.48, p < 0.001), whereas no co
rrelation was observed between plasma endotoxin levels and plasma TNF-
alpha and IL-6 levels. Plasma IL-6 levels correlated negatively with s
ystemic vascular resistance in patients with cirrhosis (r = 0.5, p < 0
.01). Conclusions: Plasma IL-6 levels are increased in patients with c
irrhosis. The severity of liver cirrhosis is an important factor for t
he occurrence of increased IL-6 levels. IL-6 may play a role in the hy
perdynamic circulation observed in patients with cirrhosis.